Abstract
In recent decades a significant scientific effort has focused on projects regarding the use of neurobiomarkers in perinatal medicine with a view to understanding the mechanisms that interfere with physiological patterns of brain development and lead to ominous effects in several human diseases. Numerous potential neurobiomarkers have been proposed for use in monitoring high-risk fetuses and newborns, including markers of oxidative stress, neuroproteins, and vasoactive agents. Nonetheless, the use of these markers in clinical practice remains a matter of debate. Recently, the calcium-binding S100B protein has been proposed as being an ideal neurobiomarker, thanks to its simple availability and easy reproducibility, to the possibility of detecting it noninvasively in biological fluids with good reproducibility, and to the possibility of a longitudinal evaluation in relation to reference curves. The present chapter contains an overview of the most significant studies on the assessment of S100B in different biological fluids as a trophic factor and/or marker of brain damage in high-risk fetuses and newborns.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Douglas-Escobar M, Weiss MD (2015) Hypoxic-ischemic encephalopathy – a review for the clinician. JAMA Pediatr 169(4):397–403
Kuschinsky W, Wahl M (1978) Local chemical and neurogenic regulation of cerebral vascular resistance. Physiol Res 58:656
Lassen NA, Christensen MS (1976) Physiology of cerebral blood flow. Br J Anaesth 48:719–734
Paulson OB, Strandgaard S, Edvinsson L (1990) Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2:161–192
Florence G, Seylaz J (1992) Rapid autoregulation of cerebral blood flow: a laser-Doppler flowmetry study. J Cereb Blood Flow Metab 12:674–680
MacKenzie ET, Strandgaard S, Graham DI et al (1976) Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 39:33–41
Mchedlishvili GI, Nikolaishvili LS, Antia RV (1976) Are the pial arterial responses dependent on the direct effect of intravascular pressure and extravascular and intravascular pO2, pCO2, and pH? Microvasc Res 10:298–311
Rubanyi GM, Botelho LH (1991) Endothelins. FASEB J 5:2713–2720
Faraci FM (1991) Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol 26:H1038–H1042
Greenberg DA, Chan J, Sampson HA (1992) Endothelins and the nervous system. Neurology 42:25–31
Harteman JC, Nikkels PG, Benders MJ et al (2013) Placental pathology in full-term infants with hypoxic-ischemic neonatal encephalopathy and association with magnetic resonance imaging pattern of brain injury. J Pediatr 163(4):968–995.e2
Wassink G, Gunn ER, Drury PP et al (2014) The mechanisms and treatment of asphyxia encephalopathy. Front Neurosci 8:40. https://doi.org/10.3389/fnins.2014.00040
Ferriero DM (2004) Neonatal brain injury. N Engl J Med 351(19):1985–1995
Bennet L, Roelfsema V, Pathipati P et al (2006) Relationship between evolving epileptiform activity and delayed loss of mitochondrial activity after asphyxia measured by near-infrared spectroscopy in preterm fetal sheep. J Physiol 572(pt 1):141–154
Bennet L, Tan S, Van den Heuij L et al (2012) Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann Neurol 71(5):589–600
Gazzolo D, Li Volti G, Gavilanes AWD et al (2015) Biomarkers of brain function and injury: biological and clinical significance. Biomed Res Int 2015:389023. https://doi.org/10.1155/2015/389023
Serpero LD, Bellissima V, Colivicchi M et al (2013) Next generation biomarkers for brain injury. J Matern Fetal Neonatal Med 26(S2):44–49
Serpero LD, Pluchinotta F, Gazzolo D (2015) The clinical and diagnostic utility of S100B in preterm newborns. Clin Chim Acta 444:193–198
Yang Q, Hamberger A, Hyden H et al (1995) S100B has a neuronal localization in the rat hindbrain revealed by an antigen retrieval method. Brain Res 696:49–61
Zuckerman JE, Herschman HR, Levine L (1970) Appearance of a brain specific antigen (the S-100 protein) during human foetal development. J Neurochem 17:247–251
Haimoto H, Hosoda S, Kato K (1987) Differential distribution of immunoreactive S100α and S100β proteins in normal non-nervous human tissues. Lab Invest 57:489–498
Michetti F, Dell’Anna E, Tiberio G et al (1983) Immunochemical and immunocytochemical study of S100 protein in rat adipocytes. Brain Res 262:352–356
Jönsson H (2003) S100B and cardiac surgery: possibilities and limitations. Restor Neurol Neurosci 21(3-4):151–157
Varrica A, Satriano A, Frigiola A et al (2015) Circulating S100B and adiponectin in children who underwent open heart surgery and cardiopulmonary bypass. Biomed Res Int 2015:402642. https://doi.org/10.1155/2015/402642
Marinoni E, Di Iorio R, Gazzolo D et al (2002) Ontogenetic localization and distribution of S100h protein in human placental tissues. Obstet Gynecol 99:1093–1099
Wijnberger LD, Nikkels PG, van Dongen AJ et al (2002) Expression in the placenta of neuronal markers for perinatal brain damage. Pediatr Res 51:492–496
Gazzolo D, Marinoni E, di Iorio R et al (2002) Circulating S100beta protein is increased in intrauterine growth-retarded fetuses. Pediatr Res 51:215–219
Jönsson H, Johnsson P, Höglund P et al (2000) Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 14:698–701
Petzold A, Eikelenboom M, Gveric D et al (2002) Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 125(Pt 7):1462–1473
Syeda T, Muhammad Hashim AS, Rizvi HA et al (2013) Serum S100B in patients with brain tumours undergoing craniotomy. J Coll Physicians Surg Pak 23(2):112–115
Chen DQ, Zhu LL (2005) Dynamic change of serum protein S100b and its clinical significance in patients with traumatic brain injury. Chin J Traumatol 8(4):245–224
Bustamante A, López-Cancio E, Pich S et al (2017) Blood biomarkers for the early diagnosis of stroke: the Stroke-Chip Study. Stroke 48(9):2419–2425
Berger RP, Pierce MC, Wisniewski SR et al (2002) Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109:E31
Hardemark HG, Ericsson N, Kotwica Z et al (1989) S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 71:727–731
Blennow M, Sävman K, Ilves P et al (2001) Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 90:1171–1175
Whitelaw A, Rosengren L, Blennow M (2001) Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch Dis Child Fetal Neonatal Ed 84(2):F90–F91
Sellman M, Ivert T, Ronquist G et al (1992) Central nervous system damage during cardiac surgery assessed by 3 different biochemical markers in cerebrospinal fluid. Scand J Thorac Cardiovasc Surg 26:39–45
Michetti F, Gazzolo D (2002) S100B protein in biological fluids: a tool for perinatal medicine. Clin Chem 48(12):2097–2104
Persson L, Hardemark HG, Gustafsson J et al (1987) S-100 protein and neurospecific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 18:911–918
Bhattacharya K, Westaby S, Pillai R et al (1999) Serum S100B and hypothermic circulatory arrest in adults. Ann Thorac Surg 68(4):1225–1229
Westaby S, Johnsson P, Parry AJ et al (1996) Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 61:88–92
Gazzolo D, Vinesi P, Geloso MC et al (1998) S100 blood concentrations in children subjected to cardiopulmonary by-pass. Clin Chem 44:1058–1060
Gazzolo D, Vinesi P, Marinoni E et al (2000) S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem 46:998–1000
Gazzolo D, Michetti F, Bruschettini M et al (2003) Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin Chem 49:967–970
Gazzolo D, Vinesi P, Bartocci M et al (1999) Elevated S100 blood level as early indicators of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 170:32–35
Gazzolo D, Masetti P, Vinesi P et al (2002) S100B blood levels correlate with rewarming time and cerebral Doppler in pediatric open heart surgery. J Card Surg 17(4):279–284
Gazzolo D, Visser GHA, Lituania M et al (2002) S100B protein cord blood levels and fetal behavioural states of development: a study in normal and small for dates fetuses. J Maternal-Fetal Neonat Med 11:378–384
Gazzolo D, Bruschettini M, Di Iorio R et al (2002) Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses. Clin Chem 48:647–650
Pawluski JL, Galea LA, Brain U et al (2009) Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics 124:e662–e670
Straus RG (1995) Neonatal anemia: pathophysiology and treatment. Immunol Invest 24:341–351
Garnier Y, Berger R, Alm S et al (2006) Systemic endotoxin administration results in increased S100B protein blood levels and periventricular brain white matter injury in the preterm fetal sheep. Eur J Obstet Gynecol Reprod Biol 124(1):15–22
Garnier Y, Frigiola A, Li Volti G et al (2009) Increased maternal/fetal blood S100B levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Reprod Sci 16:758–766
Gazzolo D, Marinoni E, Di Iorio R et al (2006) High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage. Clin Chem 52:819–826
Sannia A, Zimmermann LJ, Gavilanes AW et al (2011) S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta 412(15-16):1337–1340
Serpero LD, Bianchi V, Pluchinotta F et al (2017) S100B maternal blood levels are gestational age- and gender-dependent in healthy pregnancies. Clin Chem Lab Med 55(11):1770–1776
Moore BW (1965) A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 19:739–744
Heizmann CW (1999) Ca2+-binding S100 proteins in the central nervous system. Neurochem Res 24:1097–1100
Gazzolo D, Bruschettini M, Lituania M et al (2001) Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 47:1836–1838
Gazzolo D, Bruschettini M, Lituania M et al (2001) S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin Chem 47:1132–1133
Usai A, Kato K, Abe T et al (1989) S100ao protein in blood and urine during open-heart surgery. Clin Chem 35:1942–1944
Risso FM, Serpero LD, Zimmermann LJ et al (2012) Perinatal asphyxia: kidney failure does not affect S100B urine concentrations. Clin Chim Acta 413:150–153
Nagdyman N, Komen W, Ko HK et al (2001) Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr Res 49:502–506
Liu L, Zheng CX, Peng SF et al (2010) Evaluation of urinary S100B protein level and lactate/creatinine ratio for early diagnosis and prognostic prediction of neonatal hypoxic-ischemic encephalopathy. Neonatology 97:41–44
Florio P, Marinoni E, Di Iorio R et al (2006) Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics 118:e747–e754
Gazzolo D, Frigiola A, Bashir M et al (2009) Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One 4:e4298. https://doi.org/10.1371/journal.pone.0004298
Gazzolo D, Florio P, Ciotti S et al (2005) S100B protein in urine of preterm newborns with ominous outcome. Pediatr Res 58(6):1170–1174
Sannia A, Risso FM, Serpero LD et al (2010) Antenatal glucocorticoid treatment affects preterm infants’ S100B urine concentration in a dose-dependent manner. Clin Chim Acta 411:1539–1541
The American College of Obstetricians and Gynecologists – Women’s Health Care Physicians (2016) Practice Bulletin No. 162 Summary: prenatal diagnostic testing for genetic disorders. Obstet Gynecol 127(5):976–978
Anneren G, Esscher T, Larsson L et al (1988) S-100 protein and neuron-specific enolase in amniotic fluid as markers of abdominal wall and neural tube defects in the fetus. Prenat Diagn 8:323–328
Sindic CJ, Freund M, Van Regemorter N et al (1984) S-100 protein in amniotic fluid of anencephalic fetuses. Prenat Diagn 4:297–302
Eriksen JL, Gillespieb R, Druseb MJ (2002) Effects of ethanol and 5-HT1A agonists on astroglial S100B. Develop Brain Res 139:97–105
Clarke C, Clarke K, Muneyyirci J et al (1996) Prenatal cocaine delays astroglial maturation: immunodensitometry shows increased markers of immaturity (vimentin and GAP 43) and decreased proliferation and production of the growth factor S-100. Brain Res Dev Brain Res 91:268–273
Akbari HM, Whitaker-Azmitia PM, Azmitia E (1994) Prenatal cocaine exposure decreases the trophic factor S100b and induced microcephaly: reversal by postnatal 5-HT1A receptor agonist. Neurosci Lett 170:141–144
Michetti F, Gazzolo D (2003) S100B testing in pregnancy. Clin Chim Acta 335(1-2):1–7
Gazzolo D, Bruschettini M, Corvino V et al (2001) S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem 47:954–956
Florio P, Michetti F, Bruschettini M et al (2004) Amniotic fluid S100B protein in mid-gestation and intrauterine fetal death. Lancet 364:270–272
Humphrey SP, Williamson RT (2001) A review of saliva: normal composition, flow, and function. J Prosthet Dent 85:162–169
Gazzolo D, Michetti F (2010) Perinatal S100B protein assessment in human unconventional biological fluids: a minireview and new perspectives. Cardiovasc Psychiatry Neurol 2010:703563. https://doi.org/10.1155/2010/703563
Gazzolo D, Lituania M, Bruschettini M et al (2005) S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 38:229–233
Gazzolo D, Pluchinotta F, Bashir M et al (2015) Neurological abnormalities in full-term asphyxiated newborns and salivary S100B testing: the “Cooperative Multitask against Brain Injury of Neonates” (CoMBINe) International Study. PLoS One 10(1):e0115194. https://doi.org/10.1371/journal.pone.0115194
Michetti F, Massaro A, Murazio M (1979) The nervous system-specific S100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 11:171–175
Michetti F, Massaro A, Russo G et al (1980) The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system. J Neurol Sci 44:259–263
Fagnart OC, Sindic CJ, Laterre C (1988) Particle counting immunoassay S100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 34:1387–1391
Yang YH, Kim IK, Oh SH et al (1998) Rapid prenatal diagnosis of trisomy 21 by polymerase chain reaction-associated analysis of small tandem repeats and S100B in chromosome 21. Fetal Diagn Ther 13:361366
Zhang H, Qi S, Rao J et al (2013) Development of a rapid and high-performance chemiluminescence immunoassay based on magnetic particles for protein S100B in human serum. Luminescence 28:927–932
Gazzolo D, Frulio R, Roletti A et al (2007) S100A1B and S100BB urine levels in preterm and term healthy newborns. Clin Chim Acta 384:186–187
Sannia A, Risso FM, Zimmermann LJ et al (2013) S100B urine concentrations in late preterm infants are gestational age and gender dependent. Clin Chim Acta 417:31–34
Gazzolo D, Vinesi P, Bartocci M et al (1999) Elevated S100 blood level as early an indicator of intraventricular hemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 170:32–35
Sousa N, Madeira MD, Paula-Barbosa MM (1998) Effects of corticosteroids treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study. Brain Res 794:199–210
Lattimore KA, Donn SM, Kaciroti N et al (2005) Selective Serotonin Reuptake Inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 25:595–604
Austin MP, Kildea S, Sullivan E (2007) Maternal mortality and psychiatric morbidity in the perinatal period: challenges and opportunities for prevention in the Australian setting. Med J Aust 186(7):364–367
Noorlander CW, Ververs FF, Nikkels PG et al (2008) Modulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioural abnormalities. PLoS One 3(7):e2782. https://doi.org/10.1371/journal.pone.0002782
Hemels ME, Einarson A, Koren G et al (2005) Antidepressant use during pregnancy and the rates of spontaneous abortions; a meta-analysis. Ann Pharmacother 39:803–809
Hagberg H, Mallard C (2000) Antenatal brain injury: aetiology and possibilities of prevention. Semin Neonatol 5:41–51
Bates JA, Evans JA, Mason G (1996) Differentiation of growth retarded from normally grown fetuses and prediction of intrauterine growth retardation using Doppler ultrasound. Br J Obstet Gynaecol 103:670–675
Behrman RE, Lees MH, Peterson EN et al (1970) Distribution of the circulation in the normal and asphyxiated fetal primate. Am J Obstet Gynecol 108:956–969
Levene MI, Fenton AC, Evans DH et al (1989) Severe birth asphyxia and abnormal cerebral blood-flow velocity. Dev Med Child Neurol 31:427–434
van Bel F, van de Bor M, Stijnen T et al (1987) Cerebral blood flow velocity pattern in healthy and asphyxiated newborns: a controlled study. Eur J Pediatr 146:461–467
Fellman V, Raivio KO (1997) Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr Res 41:599–606
Florio P, Marinoni E, Di Iorio R et al (2006) Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics 118(3):e747–e754
Freeman JM, Nelson KB (1988) Intrapartum asphyxia and cerebral palsy. Pediatrics 82:240–249
Hagberg B, Hagberg G, Beckung E et al (2001) Changing panorama of cerebral palsy in Sweden: VII. Prevalence and origin in the birth year period 1991–1994. Acta Paediatr 90:271–277
Rennie JM, South M, Morely CJ (1987) Cerebral blood flow velocity variability in infants receiving assisted ventilation. Arch Dis Child 62:1247–1251
Ilves P, Talvik R, Talvik T (1998) Changes in Doppler ultrasonography in asphyxiated term infants with hypoxic-ischaemic encephalopathy. Acta Paediatr 87:680–684
Hellstrom-Westas L, Rosen I, Svenningsen NW (1995) Predictive value of early continuous amplitude EEG recordings on outcome after severe birth asphyxia in full term infants. Arch Dis Child 72:F34–F38
Huang CC, Wang ST, Chang YC et al (1999) Measurement of the urinary lactate:creatinine ratio for the early identification of newborn infants at risk from hypoxic-ischemic encephalopathy. N Engl J Med 341:328–335
Nagdyman N, Grimmer I, Scholz T et al (2003) Predictive value of brain-specific proteins in serum for neurodevelopmental outcome after birth asphyxia. Pediatr Res 54(2):270–275
Gazzolo D, Di Iorio R, Marinoni E et al (2002) S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 30(6):1356–1360
Gazzolo D, Marinoni E, Di Iorio R et al (2003) Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med 157(12):1163–1168
Gazzolo D, Marinoni E, Di Iorio R et al (2004) Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 32(1):131–136
Albuerne M, Mammola CL, Naves FJ et al (1998) Immunohistochemical localization of S100 proteins in dorsal root, sympathetic and enteric ganglia of several mammalian species, including man. J Peripher Nerv Syst 3:243–253
Hachem S, Aguirre A, Vives V et al (2005) Spatial and temporal expression of S100B in cells of oligodendrocyte lineage. Glia 51:81–97
Haglid KG, Yang Q, Hamberger A et al (1997) S-100beta stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants. Brain Res 753:196–201
Bashir M, Frigiola A, Iskander I et al (2009) Urinary S100A1B and S100BB to predict hypoxic ischemic encephalopathy at term. Front Biosci (Elite Ed) 1:560–567
Lee SK, Kim EC, Chi JG et al (1993) Immunohistochemical detection of S-100, S-100 alpha, S-100 beta proteins, glial fibrillary acidic protein, and neuron specific enolase in the prenatal and adult human salivary glands. Pathol Res Pract 189(9):1036–1043
Volpe JJ (1995) Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe JJ (ed) Neurology of the newborn. WB Saunders, Philadelphia, pp 403–463
Risso FM, Serpero LD, Zimmermann LJ et al (2013) Urine S100 BB and A1B dimers are valuable predictors of adverse outcome in full-term asphyxiated infants. Acta Paediatr 102(10):e467–e472. https://doi.org/10.1111/apa.12343
Duda I, Krzych Ł, Jędrzejowska-Szypułka H et al (2017) Serum levels of the S100B protein and neuron-specific enolase are associated with mortality in critically ill patients. Acta Biochim Pol 64(4):647–652
Sieber M, Dreßler J, Franke H et al (2018) Post-mortem biochemistry of NSE and S100B: a supplemental tool for detecting a lethal traumatic brain injury? J Forensic Leg Med 55:65–73
Crowley PA (1995) Antenatal corticosteroid therapy: a meta-analysis of the randomized trial, 1972 to 1994. Am J Obstet Gynecol 173:3223–3235
O’Shea TM, Kothadia JM, Klinepeter KL et al (1999) Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants. Pediatrics 104:15–21
Vidaeff AC, Mastrobattista JM (2001) Controversies in the use of antenatal steroids for fetal maturation. Semin Perinatol 25:385–396
Whitelaw A, Thoresen M (2000) Antenatal steroids and the developing brain. Arch Dis Child Fetal Neonatal Ed 83:154–157
Gilstrap LC, Christensen R, Clewell WH et al (1995) The effect of corticosteroids for fetal maturation on perinatal outcomes. National Institutes of Health Consensus Development Panel. JAMA 273:413–418
Mulder EJ, Derks JB, Visser GH (1997) Antenatal corticosteroid therapy and fetal behaviour: a randomized study of the effects of betamethasone and dexamethasone. Br J Obstet Gynecol 104:1239–1247
Huang WL, Beazley LD, Quinlivan JA et al (1999) Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol 94:213–218
Uno H, Lohmiller L, Thiem C et al (1990) Brain damage induced by perinatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 53:157–167
Gazzolo D, Kornacka M, Bruschettini M et al (2003) Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem 49(7):1215–1218
Lyall F, Greer IA, Young A et al (1996) Nitric oxide concentrations are increased in the feto-placental circulation in intrauterine growth restriction. Placenta 17:165–168
Di Iorio R, Marinoni E, Coacci F et al (1997) Amniotic fluid nitric oxide and uteroplacental blood flow in pregnancy complicated by intrauterine growth retardation. Br J Obstet Gynaecol 104:1134–1139
Cacciatore B, Halmesmaki E, Kaaja R et al (1998) Effects of transdermal nitroglycerin on impedance to flow in the uterine, umbilical, and fetal middle cerebral arteries in pregnancies complicated by preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol 179:140–145
Grunewald C, Kublickas M, Carlström K et al (1995) Effects of nitroglycerin on the uterine and umbilical circulation in severe preeclampsia. Obstet Gynecol 86:600–604
Bennett HA, Einarson A, Taddio A et al (2004) Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 103:698–709
Austin MP (2006) To treat or not to treat: maternal depression. SSRI use in pregnancy and adverse neonatal effects. Psychol Med 36(12):1663–1670
Bellissima V, Ververs TF, Visser GH et al (2012) Selective serotonin reuptake inhibitors in pregnancy. Curr Med Chem 19(27):4554–4561
Moses-Kolko EL, Bogen D, Perel J et al (2005) Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293:2372–2383
Louik C, Lin AE, Werler MM et al (2007) First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675–2683
Latendresse G, Ruiz RJ (2011) Maternal corticotropin-releasing hormone and the use of selective serotonin reuptake inhibitors independently predict the occurrence of preterm birth. J Midwifery Womens Health 56:118–126
Kallen BA, Otterblad Olausson P (2007) Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79:301–308
Levinson-Castiel R, Merlob P, Linder N et al (2006) Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 160:173–176
Bellissima V, Vesser GHA, Tessa F (2015) Antenatal maternal antidepressants drugs affect S100B concentrations in fetal-maternal biological fluids. CNS Neurol Disord Drug Targets 14(1):49–54
Azzopardi DV, Strohm B, Edwards AD et al (2009) Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 361:1349–1358
Edwards AD, Brocklehurst P, Gunn AJ et al (2010) Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 340:c363. https://doi.org/10.1136/bmj.c363
Massaro AN, Chang T, Baumgart S et al (2014) Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns. Pediatr Crit Care Med 15(7):615–622
Massaro AN, Chang T, Kadom N et al (2012) Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia. J Pediatr 161(3):434–440
Roka A, Kelen D, Halasz J et al (2012) Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr 101(3):319–323
Massaro AN, Wu YW, Bammler TK et al (2018) Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy. J Pediatr 194:67–75
Çelik Y, Atıcı A, Gülaşı S et al (2015) The effects of selective head cooling versus whole-body cooling on some neural and inflammatory biomarkers: a randomized controlled pilot study. Ital J Pediatr 41:79
Alshweki A, Pérez-Muñuzuri A, López-Suárez O et al (2017) Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia. Medicine 96(44):e8453. https://doi.org/10.1097/MD.0000000000008453
Abella R, Varrica A, Satriano A et al (2015) Biochemical markers for brain injury monitoring in children with or without congenital heart diseases. CNS Neurol Disord Drug Targets 14(1):12–23
Newburger JW, Jonas JA, Wernovsky G (1993) A comparison of the perioperative neurologic effects of hypothermic circulatory arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N Engl J Med 329:1057–1064
Bellinger D, Wypij D, duPlessis AJ et al (2003) Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 126:1385–1396
Bellinger DC, Jonas RA, Rappaport LA et al (1995) Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 332:549–555
Bellinger DC, Rappaport LA, Wypij D et al (1997) Patterns of developmental dysfunction after surgery during infancy to correct transposition of the great arteries. J Dev Behav Pediatr 18:75–83
Bellinger DC, Wernovsky G, Rappaport LA et al (1991) Cognitive development of children following early repair of transposition of the great arteries using deep hypothermic circulatory arrest. Pediatrics 87:701–707
Arrica M, Bissonnette B (2007) Therapeutic hypothermia. Semin Cardiothorac Vasc Anesth 11:6–15
Alcaraz AJ, Manzano L, Sancho L et al (2005) Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol 25:238–245
Golej J, Trittenwein G (1999) Early detection of neurologic injury and issues of rehabilitation after pediatric cardiac extracorporeal membrane oxygenation. Artif Organs 23:1020–1025
Trakas E, Domnina Y, Panigrahy A et al (2017) Serum neuronal biomarkers in neonates with congenital heart disease undergoing cardiac surgery. Pediatr Neurol 72:56–61
Yuan SM (2014) S100 and S100β: biomarkers of cerebral damage in cardiac surgery with or without the use of cardiopulmonary bypass. Rev Bras Cir Cardiovasc 29(4):630–641 + 40 192,193
Varrica A, Satriano A, Tettamanti G et al (2015) Predictors of ominous outcome in infants undergone to cardiac surgery and cardiopulmonary by-pass: S100B protein. CNS Neurol Disord Drug Targets 14:1
Varrica A, Satriano A, Gavilanes ADW et al (2017) S100B increases in cyanotic versus noncyanotic infants undergoing heart surgery and cardiopulmonary bypass (CPB). J Matern Fetal Neonatal Med 28:1–7
Gazzolo D, Bruschettini M, Lituania M et al (2004) Levels of S100B protein are higher in mature human milk than in colostrum and milk-formulae milks. Clin Nutr 23:23–26
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Gazzolo, D., Pluchinotta, F., Lapergola, G., Franchini, S. (2019). The Ca2+-Binding S100B Protein: An Important Diagnostic and Prognostic Neurobiomarker in Pediatric Laboratory Medicine. In: Heizmann, C. (eds) Calcium-Binding Proteins of the EF-Hand Superfamily. Methods in Molecular Biology, vol 1929. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9030-6_44
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9030-6_44
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9029-0
Online ISBN: 978-1-4939-9030-6
eBook Packages: Springer Protocols